18-Oct-2026 09:59:39

BAJAJ HEALTHCARE Q2 FY27: FORMULATIONS REVENUE SURGES 82% YOY; API EXPORTS UP 28.5% 🟢

• DOMESTIC API: Revenue down 6.2% YoY to ₹71.6 CR vs ₹76.3 CR. • API EXPORTS: Revenue up 28.5% YoY and 25.1% QoQ to ₹62.6 CR. • FORMULATIONS: Revenue up 82% YoY and 79% QoQ to ₹41.7 CR. • NEW LAUNCH: Launched Cenobamate in India through marketing partners. • H1 DOMESTIC API: Revenue up 10.1% YoY to ₹163.9 CR.

BAJAJ HEALTHCARE LIMITED

← Back to feed